AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9278834 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 mg hyperbaric bupivacaine + saline)
Number of subjects: 60
Study 7761013 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat and moisture exchangers (HMEs)
Number of subjects: 28
Study 2527542 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 mg once a day
Number of subjects: 20
Study 2527542 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg twice daily
Number of subjects: 20
Study 2527542 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin plus placebo
Number of subjects: 20
Study 2527542 — intervention group
Group type: COMPARATOR
Intervention: Cilazapril plus placebo
Number of subjects: 20
Study 2527542 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 20
Study 921245 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin (1,000 mg/day in four divided doses)
Number of subjects: 29
Study 921245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 921245 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 29
Study 30658942 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetric split-dose regimen (25% on the day of colonoscopy and 75% the day before)
Number of subjects: 161
Study 30658942 — intervention group
Group type: COMPARATOR
Intervention: Symmetric split-dose regimen (standard split-dose)
Number of subjects: 161
Study 26471240 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory physiotherapy session
Number of subjects: 30
Study 25477199 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular low-level alcohol consumption
Number of subjects: 29
Study 25477199 — intervention group
Group type: COMPARATOR
Intervention: Non-users of alcohol
Number of subjects: 29
Study 24642116 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care lactate measurement (fingerstick whole-blood lactate measurement)
Number of subjects: 59
Study 24642116 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-lactate measurement)
Number of subjects: 59
Study 21803780 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental amalgam fillings
Number of subjects: 0
Study 21803780 — intervention group
Group type: COMPARATOR
Intervention: No dental amalgam fillings
Number of subjects: 0
Study 19434420 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) group (n = 18) performed three times/week a static exercise on a vibration platform (6 sets of 1‐min with 1 min of rest, with a 12.6 Hz of frequency and an amplitude of 3 mm)
Number of subjects: 27
Study 19434420 — intervention group
Group type: COMPARATOR
Intervention: Walk-based program (WP) group (n = 18) performed three times/week a 60‐min of walk activity at 70‐75% of maximal heart rate
Number of subjects: 27
Study 17299499 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (2.7 g long-chain n-3 fatty acids per day from week 20 for groups 1 and 2; 6.3 g from week 33 for group 3)
Number of subjects: 968
Study 17299499 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 968
Study 17299499 — intervention group
Group type: COMPARATOR
Intervention: Control (olive oil capsules)
Number of subjects: 968
Study 15384144 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleotide depletion primer extension assay for SNP determination
Number of subjects: 0
Study 15384144 — intervention group
Group type: EXPERIMENTAL
Intervention: MALDI-TOFMS technique for SNP determination
Number of subjects: 0
Study 11273850 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g American ginseng
Number of subjects: 12
Study 11273850 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g American ginseng
Number of subjects: 12
Study 11273850 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g American ginseng
Number of subjects: 12
Study 11273850 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 g)
Number of subjects: 12
Study 11273850 — intervention group
Group type: EXPERIMENTAL
Intervention: American ginseng administered 40 min before glucose challenge
Number of subjects: 12
Study 9340441 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulizer therapy (0.5 ml ‐ 125 micrograms ipratropium bromide and 250 micrograms phenoterol)
Number of subjects: 34
Study 9340441 — intervention group
Group type: COMPARATOR
Intervention: Aerosol therapy (40 micrograms ipratropium and 100 micrograms phenoterol)
Number of subjects: 34
Study 1285936 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nitrendipine twice daily (titrated up to 30 mg twice daily during open label period)
Number of subjects: 32
Study 1285936 — intervention group
Group type: COMPARATOR
Intervention: 50 mg hydrochlorothiazide daily
Number of subjects: 32
Study 3809304 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramin, 50 mg (oral)
Number of subjects: 8
Study 3809304 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptylin, 50 mg (oral)
Number of subjects: 8
Study 3809304 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramin, 50 mg (oral)
Number of subjects: 8
Study 3809304 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramin, 50 mg (oral)
Number of subjects: 8
Study 3809304 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam, 10 mg (oral)
Number of subjects: 8
Study 3809304 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepin, 200 mg (oral)
Number of subjects: 8
Study 3809304 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol, 3 mg (oral)
Number of subjects: 8
Study 3809304 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramin, 25 mg (intravenous)
Number of subjects: 8
Study 3809304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 28753136 — intervention group
Group type: EXPERIMENTAL
Intervention: Coach2Move
Number of subjects: 130
Study 28753136 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study 30442157 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitation interventions (two types)
Number of subjects: 16
Study 26715229 — intervention group
Group type: COMPARATOR
Intervention: PCBT‐I (n = 81)
Number of subjects: 242
Study 26715229 — intervention group
Group type: COMPARATOR
Intervention: VCBT‐I (n = 80)
Number of subjects: 242
Study 26715229 — intervention group
Group type: COMPARATOR
Intervention: CTL (n = 81)
Number of subjects: 242
Study 25117873 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training of the dominant limb with a dynamometer in eccentric mode at 60°/s, 3 times per week for 8 weeks
Number of subjects: 18
Study 25117873 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study 25117873 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 18
Study 21793769 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed low-dose oxytocin
Number of subjects: 116
Study 21793769 — intervention group
Group type: COMPARATOR
Intervention: Standard incremental low-dose oxytocin
Number of subjects: 116
Study 20954779 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based leaflet plus five postcards facilitating recruitment and donor registration
Number of subjects: 734
Study 20954779 — intervention group
Group type: EXPERIMENTAL
Intervention: Five postcards alone
Number of subjects: 734
Study 20954779 — intervention group
Group type: COMPARATOR
Intervention: No materials
Number of subjects: 734
Study 20954779 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcards plus leaflet
Number of subjects: 734
Study 20954779 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcards alone
Number of subjects: 734
Study 17021740 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.25%
Number of subjects: 60
Study 17021740 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.25% plus 50 mg magnesium
Number of subjects: 60
Study 15723860 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified total-etch and self-etch adhesives
Number of subjects: 0
Study 15723860 — intervention group
Group type: COMPARATOR
Intervention: Control three-step total-etch adhesive
Number of subjects: 0
Study 11913290 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.5% hydrogen peroxide strip system, used twice daily for 30 minutes (total of 56 contact hours over 8 weeks)
Number of subjects: 106
Study 11913290 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide tray system, used overnight (approximately 448 contact hours)
Number of subjects: 106
Study 11913290 — intervention group
Group type: COMPARATOR
Intervention: Both systems
Number of subjects: 106
Study 9707740 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole; specific dosage and duration not mentioned.
Number of subjects: 0
Study 9707740 — intervention group
Group type: COMPARATOR
Intervention: Placebo; specific dosage and duration not mentioned.
Number of subjects: 0
Study 8551804 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with < or = 5% residual blasts at D15
Number of subjects: 437
Study 8551804 — intervention group
Group type: COMPARATOR
Intervention: Induction chemotherapy with > 5% residual blasts at D15
Number of subjects: 437
Study 2246174 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine inhalation tests in normal subjects
Number of subjects: 24
Study 2246174 — intervention group
Group type: COMPARATOR
Intervention: Methacholine inhalation tests in asthmatic subjects
Number of subjects: 24
Study 2246174 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (100 mg/day) and flurbiprofen (150 mg/day) pretreatment in normal subjects
Number of subjects: 24
Study 6936982 — intervention group
Group type: EXPERIMENTAL
Intervention: treatment with a mixture of 7 grass pollen extracts (Allpyral)
Number of subjects: 128
Study 6936982 — intervention group
Group type: EXPERIMENTAL
Intervention: treatment with a cocksfoot pollen extract (Allpyral)
Number of subjects: 128
Study 6936982 — intervention group
Group type: EXPERIMENTAL
Intervention: treatment with a rye pollen extract (Allpyral)
Number of subjects: 128
Study 6936982 — intervention group
Group type: EXPERIMENTAL
Intervention: treatment with a mixture containing 50% rye pollen and 50% cocksfoot (Allpyral)
Number of subjects: 128
Study 6936982 — intervention group
Group type: COMPARATOR
Intervention: control group without immunotherapy
Number of subjects: 128
Study 31898177 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (DDAVP)
Number of subjects: 202
Study 31898177 — intervention group
Group type: COMPARATOR
Intervention: No Desmopressin (Control)
Number of subjects: 202
Study 30427055 — intervention group
Group type: EXPERIMENTAL
Intervention: Subscapularis-sparing total shoulder arthroplasty (SPARING)
Number of subjects: 70
Study 30427055 — intervention group
Group type: COMPARATOR
Intervention: Standard total shoulder arthroplasty (STANDARD)
Number of subjects: 70
Study 28899951 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-IL-12/23 (ustekinumab)
Number of subjects: 150
Study 26324784 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 99
Study 26324784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 26324784 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians' adherence
Number of subjects: 99
Study 26324784 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 99
Study 24020078 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP combined with antireflux medicine (esomeprazole 40 mg/d and mosapride citrate 5 mg, 3 times a day, oral)
Number of subjects: 60
Study 24020078 — intervention group
Group type: COMPARATOR
Intervention: nCPAP alone
Number of subjects: 60
Study 24020078 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP combined with antireflux medicine
Number of subjects: 60
Study 21770847 — intervention group
Group type: EXPERIMENTAL
Intervention: Values writing intervention
Number of subjects: 0
Study 21770847 — intervention group
Group type: COMPARATOR
Intervention: Neutral writing task (control)
Number of subjects: 0
Study 19645974 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% levobupivacaine or bupivacaine (Treatment Group)
Number of subjects: 72
Study 19645974 — intervention group
Group type: COMPARATOR
Intervention: Saline (Placebo Group)
Number of subjects: 72
Study 17302060 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) - glucosidorum tripterygll totorum and Yishen Juanbi Pill
Number of subjects: 356
Study 17302060 — intervention group
Group type: EXPERIMENTAL
Intervention: Western Medicine (WM) - non-steroidal anti-inflammatory drugs and slow-acting anti-rheumatic drugs
Number of subjects: 356
Study 17302060 — intervention group
Group type: COMPARATOR
Intervention: Control group (ineffective treatment)
Number of subjects: 356
Study 15217308 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (Lescol) 40 mg twice daily plus dietary counselling
Number of subjects: 77
Study 15217308 — intervention group
Group type: COMPARATOR
Intervention: Control group (dietary counselling only)
Number of subjects: 77
Study 11216808 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (4 mg/kg intraoperatively and 2.0 +/- 0.5 mg/kg once daily for 3 months)
Number of subjects: 13
Study 11216808 — intervention group
Group type: COMPARATOR
Intervention: Control (no azathioprine)
Number of subjects: 13
Study 11216808 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 13
Study 9773716 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE) at 0.625 mg/day
Number of subjects: 788
Study 9773716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 788
Study 9773716 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) at 2.5 mg daily (continuous MPA)
Number of subjects: 788
Study 9773716 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) at 10 mg on days 1-12 (cyclical MPA)
Number of subjects: 788
Study 9773716 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized progesterone (MP) at 200 mg on days 1-12 (cyclical)
Number of subjects: 788
Study 7848884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg
Number of subjects: 217
Study 7848884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 2 mg
Number of subjects: 217
Study 7848884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg (rescue infusion)
Number of subjects: 217
Study 7848884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg, 10 mg, 20 mg, 40 mg (study I)
Number of subjects: 217
Study 7848884 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 217
Study 3141867 — intervention group
Group type: EXPERIMENTAL
Intervention: Active allergen injection during treatment sessions
Number of subjects: 33
Study 3141867 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection during treatment sessions
Number of subjects: 33
Study 3141867 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralization subcutaneous treatment
Number of subjects: 33
Study 29384754 — intervention group
Group type: EXPERIMENTAL
Intervention: Knocking-fingers (KF) technique
Number of subjects: 0
Study 29384754 — intervention group
Group type: COMPARATOR
Intervention: Two-finger (TF) technique
Number of subjects: 0
Study 29384754 — intervention group
Group type: COMPARATOR
Intervention: Two-thumb encircling hands (TT) technique
Number of subjects: 0
Study 27624148 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg of oral THC twice daily
Number of subjects: 18
Study 27624148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 25781888 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide with facilitation support through workshops for managers and ongoing support
Number of subjects: 26
Study 25781888 — intervention group
Group type: COMPARATOR
Intervention: Control group conducting programs as usual
Number of subjects: 26
Study 25781888 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 26
Study 25781888 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study 24696926 — intervention group
Group type: EXPERIMENTAL
Intervention: In‐dwelling catheter removed after 24 hours (Group A)
Number of subjects: 100
Study 24696926 — intervention group
Group type: COMPARATOR
Intervention: In‐dwelling catheter removed after 72 hours (Group B)
Number of subjects: 100
Study 20865457 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided femoro-popliteal block (US-FPB)
Number of subjects: 40
Study 20865457 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (SA)
Number of subjects: 40
Study 18843961 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) 1 g thrice daily during menstrual cycle days 1-5
Number of subjects: 131
Study 18843961 — intervention group
Group type: COMPARATOR
Intervention: Norethisterone (NET) 5 mg twice daily on days 19-26
Number of subjects: 131
Study 16849704 — intervention group
Group type: EXPERIMENTAL
Intervention: FreeStyle Flash
Number of subjects: 100
Study 16849704 — intervention group
Group type: COMPARATOR
Intervention: One Touch Ultra
Number of subjects: 100
Study 14690339 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 137
Study 14690339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 14690339 — intervention group
Group type: EXPERIMENTAL
Intervention: Low number of cultured Malassezia yeasts
Number of subjects: 137
Study 11737343 — intervention group
Group type: EXPERIMENTAL
Intervention: Concorde trial participants
Number of subjects: 0
Study 11737343 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta trial participants
Number of subjects: 0
Study 11737343 — intervention group
Group type: COMPARATOR
Intervention: Non-enrolled participants
Number of subjects: 0
Study 8695137 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.25 mg/kg
Number of subjects: 200
Study 8695137 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 20 ug/kg
Number of subjects: 200
Study 8695137 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2 ug/kg
Number of subjects: 200
Study 8695137 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 200
Study 1627437 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (CMFP) consisting of six 4-week cycles of cyclophosphamide (100 mg/m2 orally days 1-14), methotrexate (40 mg/m2 IV days 1 and 8), fluorouracil (600 mg/m2 IV days 1 and 8), and prednisone (40 mg/m2 orally days 1-14)
Number of subjects: 1191
Study 1627437 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1191
Study 6692322 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenalectomy
Number of subjects: 51
Study 6692322 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (Nolvadex)
Number of subjects: 51
Study 6692322 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen after adrenalectomy
Number of subjects: 51
Study 6692322 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenalectomy after tamoxifen
Number of subjects: 51
Study 6692322 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenalectomy (primary and secondary therapy)
Number of subjects: 51
Study 6692322 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (primary and secondary therapy)
Number of subjects: 51
Study 31163337 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle biopsy (performed in 969 patients, 33% of total)
Number of subjects: 2971
Study 31163337 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk histology
Number of subjects: 2971
Study 31163337 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥ 2 years
Number of subjects: 2971
Study 31163337 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative tumour volume
Number of subjects: 2971
Study 29335932 — intervention group
Group type: EXPERIMENTAL
Intervention: FORTA List (2015 version)
Number of subjects: 47
Study 29335932 — intervention group
Group type: EXPERIMENTAL
Intervention: Delphi consensus validations
Number of subjects: 47
Study 27283377 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 international units)
Number of subjects: 60
Study 27283377 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 60
Study 25153936 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-chosen relaxing music
Number of subjects: 123
Study 25153936 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-chosen happy music
Number of subjects: 123
Study 25153936 — intervention group
Group type: COMPARATOR
Intervention: Audio book
Number of subjects: 123
Study 25153936 — intervention group
Group type: COMPARATOR
Intervention: Silence
Number of subjects: 123
Study 22581111 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (379 mg daily for 3 months)
Number of subjects: 46
Study 22581111 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 46
Study 20471761 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-only therapies
Number of subjects: 0
Study 20471761 — intervention group
Group type: COMPARATOR
Intervention: Estrogen-plus-progestin therapies
Number of subjects: 0
Study 17872548 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy and referral to Gamblers Anonymous (GA)
Number of subjects: 231
Study 15734179 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive-behavioral therapy (TF-CBT)
Number of subjects: 82
Study 15734179 — intervention group
Group type: COMPARATOR
Intervention: Non-directive supportive therapy (NST)
Number of subjects: 82
Study 12135945 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcoronary ablation of septal hypertrophy (TASH)
Number of subjects: 129
Study 9949706 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing at preferred (optimal) times of day
Number of subjects: 316
Study 9949706 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing at nonpreferred (nonoptimal) times of day
Number of subjects: 316
Study 9949706 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger adults
Number of subjects: 316
Study 9949706 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 316
Study 7775344 — intervention group
Group type: COMPARATOR
Intervention: C
Number of subjects: 35
Study 7775344 — intervention group
Group type: EXPERIMENTAL
Intervention: UC
Number of subjects: 35
Study 7775344 — intervention group
Group type: EXPERIMENTAL
Intervention: E
Number of subjects: 35
Study 7775344 — intervention group
Group type: EXPERIMENTAL
Intervention: ST
Number of subjects: 35